CN Patent

CN108289896B — 抗菌药物组合的组合物和使用方法

Assigned to University of Washington · Expires 2022-03-01 · 4y expired

What this patent protects

本公开涵盖抗菌组合物和治疗由抗性细菌引起的细菌感染的方法。

USPTO Abstract

本公开涵盖抗菌组合物和治疗由抗性细菌引起的细菌感染的方法。

Drugs covered by this patent

Merrem (Meropenem) · Pfizer

Patent Metadata

Patent number: CN108289896B
Jurisdiction: CN
Classification: —
Expires: 2022-03-01
Drug substance claim: No
Drug product claim: No
Assignee: University of Washington
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.